Cornelia de Wolf
YOU?
Author Swipe
View article: Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
View article: Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
View article: Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
View article: Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Fig. S1 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
View article: Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Figure Legends from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
View article: Data from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Data from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
We have studied the potential contribution of ABCG2 (breast cancer resistance protein) to resistance to nucleoside analogues. In cells transfected with DNA constructs resulting in overexpression of human or mouse ABCG2, we found resistance…
View article: Data from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Data from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
We have studied the potential contribution of ABCG2 (breast cancer resistance protein) to resistance to nucleoside analogues. In cells transfected with DNA constructs resulting in overexpression of human or mouse ABCG2, we found resistance…
View article: Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides Open
Supplementary Fig. S2 from Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides